Oral Session 3-13C Fungal infection

[OS3-13C-2] Efficacy and safety of caspofungin for FN patients: a multicenter retrospective study

Kazuhiro Itoh¹, Hiromichi Iwasaki², Keiichi Kinoshita⁴, Hikaru Tsukasaki⁴, Katsunori Tai^1,2, Shin Imamura⁴, Koji Morinaga⁵, Nobuyuki Yoshio⁶, Takashi Nakayama⁷, Hitoshi Inoue⁸, Hiroko Shigemi^2,3, Takanori Ueda¹, Takahiro Yamauchi¹ (1.First Department of Internal Medicine, University of Fukui, Fukui, Japan, 2.Department of Infection Control and Prevention, University of Fukui, 3.Third Department of Internal Medicine, University of Fukui, 4.Department of Hematology and Immunology, Fukui Red Cross Hospital, 5.Department of Hematology and Oncology, Fukui Prefectural Hospital, Fukui, Japan, 6.Department of Hematology, Kanazawa Medical Center, Kanazawa, Japan, 7.Department of Oncology and Hematology, Fukui-ken Saiseikai Hospital, Fukui, Japan, 8.Department of Hematology, Tsuruga Medical Center, Tsuruga, Japan)